Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹532 Cr
Revenue (TTM)
₹105 Cr
Net Profit (TTM)
₹13 Cr
ROE
45.4 %
ROCE
60.1 %
P/E Ratio
39.8
P/B Ratio
12.9
Industry P/E
36.2
EV/EBITDA
25.6
Div. Yield
0 %
Debt to Equity
0
Book Value
₹19.9
EPS
₹7.4
Face value
10
Shares outstanding
23,150,400
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Influx Healthtech
| 1.6 | 3.5 | -1.3 | -- | -- | -- | -- |
|
BSE FMCG
| -12.6 | -3.6 | -10.1 | -8.5 | 2.0 | 6.5 | 8.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Influx Healthtech
|
229.8 | 532.0 | 104.9 | 13.4 | -- | 45.4 | 39.8 | 12.9 |
| 55.9 | 79.2 | 61.6 | 6.0 | -- | 33.8 | 13.1 | 2.9 | |
| 389.5 | 5,075.2 | 1,088.6 | 156.8 | 15.0 | 22.6 | 32.2 | 7.3 | |
| 417.3 | 18,219.5 | 3,817.5 | 798.5 | 21.4 | 28.6 | 22.9 | 5.6 | |
| 224.8 | 8,256.8 | 2,892.8 | 342.7 | 14.0 | 24.5 | 24.1 | 5.4 | |
| 262.2 | 397.9 | 221.4 | -75.4 | -23.1 | -- | -- | -3.0 | |
| 47.3 | 91.7 | 308.8 | 3.9 | 1.5 | 10.9 | 23.9 | 2.4 | |
| 66.9 | 163.0 | 392.0 | -4.7 | 0.9 | -2.7 | -- | 1.0 | |
| 353.0 | 789.8 | 107.5 | 16.0 | -- | 29.6 | 49.4 | 11.6 | |
| 481.9 | 15,410.1 | 3,389.4 | 207.1 | 9.5 | 4.4 | 74.4 | 2.7 |
No Review & Analysis are available.
--
Incorporated
2020
Chairman
Munir Abdul Ganee Chandniwala
Managing Director
Munir Abdul Ganee Chandniwala
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Influx Healthtech Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Influx Healthtech Ltd is ₹229.80 (NSE) as of 08-Apr-2026 IST. Influx Healthtech Ltd has given a return of --% in the last 1 years.
The P/E ratio of Influx Healthtech Ltd is 39.80 times as on 08-Apr-2026, a 10 premium to its peers’ median range of 36.20 times.
The P/B ratio of Influx Healthtech Ltd is 12.93 times as on 08-Apr-2026, a 76 premium to its peers’ median range of 7.34 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
The 52-week high and low of Influx Healthtech Ltd are Rs 261.95 and Rs 120.00 as of 09-Apr-2026.
Influx Healthtech Ltd has a market capitalisation of ₹ 532 Cr as on 08-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Influx Healthtech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹10.90
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.